AZBio

05/19/2016

The mHealth Revolution

Kent Dicks, Life365, RAIN

AZBio

05/19/2016

Prediction and Prevention - Medicine in the Age of Information (Panel)

Moderated by Chris Yoo, Founder, Chairman & CEO, Systems Imagination; Panelists- Ron Korn, MD PhD, Founder, Chairman and Chief Medical Officer, Imaging Endpoints; Scott Jenkins, PhD, Chairman & CEO, RealTime Oncology, Todd Huffman, CEO, 3Scan  

AZBio

05/19/2016

Purpose Driven Innovation

Presented by Matthew Likens, President and Chief Executive Officer, Ulthera division of Merz Pharma  

Mr. Likens joined Ulthera in July of 2006. He spent more than twenty years in domestic and international sales, marketing and general management roles at Baxter Healthcare Corporation, culminating in the positions of President of Baxter Biotech North America, then President of Baxter’s Renal Division in the U.S. In 2001, Mr. Likens joined GMP Companies, and was President of GMP Wireless Medicine, Inc.

AZBio

07/14/2014

White Space Enterprise Corporation

Frederic Zenhausern, Ph.D., MBA, President, WhiteSpace Enterprise Corporation (“WSE”) is developing platform technologies and commercial products combining methods from physical sciences and integrated microsystems for automating and miniaturizing the workflow processing of biological specimens. These platforms have broad applications for point-of-care testing that will enable precise and mobile health analysis ranging from rapid DNA analysis to predictive biomarkers for molecular diagnostics. The company’s design of genomic and proteomic biomarkers panel for monitoring radiation sensitivities will provide new ways for guiding personalized treatment in radiotherapies that that will improve value in healthcare delivery.

AZBio

06/15/2017

Systems Imagination - 2017 AZBio Fast Lane Honoree

AZBio

05/17/2013

Student Discovery Zone 2011

EmpowHER reports on the work being done by Arizona's future bioscience leaders as students from across the  state displayed their work and connected with today's bioscience leaders.

AZBio

06/15/2017

GlobalMed - 2017 Arizona Bioscience Company of the Year

AZBio

09/30/2015

Wayne D Frasch 2015 Bioscience Researcher of the Year

AZBio

07/22/2014

Insys Therapeutics

Reaching Your Destination – An Arizona Success Story

Darryl Baker, Chief Financial Officer of Insys Therapeutics, Inc.

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company based in Chandler, Arizona that develops and commercializes innovative supportive care products. In one of the hottest years for biotech IPO’s in recent memory, Insys was the top performing IPO of 2013 with over 380% growth in shareholder value and a market cap in excess of $800 million at the end of the year.Join us as Darryl Baker, Chief Financial Officer  of Insys, shares insights from their journey and  takes a look at the road ahead.Learn more about Darryl.

AZBio

07/04/2014

Remembering Polio

Remembering Polio

Polio, or poliomyelitis, is an infectious viral disease that can strike at any age and affects a person’s nervous system. In the late 1940s to the early 1950s, polio crippled an average of more than 35,000 people in the United States each year; it was one of the most feared diseases of the twentieth century. Thanks to the polio vaccine, dedicated health care professionals, and parents who vaccinate their children on schedule, polio has been eliminated in this country for more than 30 years. (Source: CDC)  Today the US is home to approximately 1 million polio survivors.  Join our panelists in a look at what polio was, the impacts polio has on Americans today, and the importance of vaccinations in our ever shrinking world.Moderator: Gapar Laca, State Government Affairs Director at GlaxoSmithKlinePanelists:  David Larwood, CEO, President – Valley Fever Solutions, Debbie McCune Davis, Executive Director, The Arizona Partnership for Immunization (TAPI)